These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 34591864)

  • 1. Multiphase evaluation of portable medicines quality screening devices.
    Caillet C; Vickers S; Zambrzycki S; Luangasanatip N; Vidhamaly V; Boutsamay K; Boupha P; Lubell Y; Fernández FM; Newton PN
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009287. PubMed ID: 34591864
    [No Abstract]   [Full Text] [Related]  

  • 2. Laboratory evaluation of twelve portable devices for medicine quality screening.
    Zambrzycki SC; Caillet C; Vickers S; Bouza M; Donndelinger DV; Geben LC; Bernier MC; Newton PN; Fernández FM
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009360. PubMed ID: 34591844
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implementation of field detection devices for antimalarial quality screening in Lao PDR-A cost-effectiveness analysis.
    Luangasanatip N; Khonputsa P; Caillet C; Vickers S; Zambrzycki S; Fernández FM; Newton PN; Lubell Y
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009539. PubMed ID: 34591842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative field evaluation of six medicine quality screening devices in Laos.
    Caillet C; Vickers S; Zambrzycki S; Fernández FM; Vidhamaly V; Boutsamay K; Boupha P; Peerawaranun P; Mukaka M; Newton PN
    PLoS Negl Trop Dis; 2021 Sep; 15(9):e0009674. PubMed ID: 34591852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Usefulness of combined screening methods for rapid detection of falsified and/or substandard medicines in the absence of a confirmatory method.
    Opuni KF; Nettey H; Larbi MA; Amartey SNA; Nti G; Dzidonu A; Owusu-Danso P; Owusu NA; Nyarko AK
    Malar J; 2019 Dec; 18(1):403. PubMed ID: 31805937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Research on the Development of Methods for Detection of Substandard and Falsified Medicines by Clarifying Their Pharmaceutical Characteristics Using Modern Technology.
    Yoshida N
    Biol Pharm Bull; 2024; 47(5):878-885. PubMed ID: 38692863
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemometrics and the identification of counterfeit medicines-A review.
    Krakowska B; Custers D; Deconinck E; Daszykowski M
    J Pharm Biomed Anal; 2016 Aug; 127():112-22. PubMed ID: 27133184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessment of the effectiveness of the CD3+ tool to detect counterfeit and substandard anti-malarials.
    Batson JS; Bempong DK; Lukulay PH; Ranieri N; Satzger RD; Verbois L
    Malar J; 2016 Feb; 15():119. PubMed ID: 26917250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excessive active pharmaceutical ingredients in substandard and falsified drugs should also raise concerns in low-income countries.
    Maffioli EM; Montás MC; Anyakora C
    J Glob Health; 2024 Jun; 14():03029. PubMed ID: 38843042
    [No Abstract]   [Full Text] [Related]  

  • 10. Evaluating Low-Cost Optical Spectrometers for the Detection of Simulated Substandard and Falsified Medicines.
    Wang W; Keller MD; Baughman T; Wilson BK
    Appl Spectrosc; 2020 Mar; 74(3):323-333. PubMed ID: 31617368
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of portable devices for medicine quality screening: Lessons learnt, recommendations for implementation, and future priorities.
    Caillet C; Vickers S; Vidhamaly V; Boutsamay K; Boupha P; Zambrzycki S; Luangasanatip N; Lubell Y; Fernández FM; Newton PN
    PLoS Med; 2021 Sep; 18(9):e1003747. PubMed ID: 34591861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of the performance of a handheld Raman device for potential use as a screening tool in evaluating medicines quality.
    Hajjou M; Qin Y; Bradby S; Bempong D; Lukulay P
    J Pharm Biomed Anal; 2013 Feb; 74():47-55. PubMed ID: 23245232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
    Khurelbat D; Dorj G; Sunderland B; Sanjjav T; Bayarsaikhan E; Damdinjav D; Dorj G; Jigjidsuren A; Lkhagvasuren O; Erdenetsetseg B
    BMC Public Health; 2020 May; 20(1):743. PubMed ID: 32434489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a colloidal gold-based lateral flow dipstick immunoassay for rapid qualitative and semi-quantitative analysis of artesunate and dihydroartemisinin.
    He L; Nan T; Cui Y; Guo S; Zhang W; Zhang R; Tan G; Wang B; Cui L
    Malar J; 2014 Mar; 13():127. PubMed ID: 24678609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A New Handheld Device for the Detection of Falsified Medicines: Demonstration on Falsified Artemisinin-Based Therapies from the Field.
    Wilson BK; Kaur H; Allan EL; Lozama A; Bell D
    Am J Trop Med Hyg; 2017 May; 96(5):1117-1123. PubMed ID: 28219992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combatting substandard and falsified medicines: a view from Rwanda.
    Binagwaho A; Bate R; Gasana M; Karema C; Mucyo Y; Mwesigye JP; Biziyaremye F; Nutt CT; Wagner CM; Jensen P; Attaran A
    PLoS Med; 2013; 10(7):e1001476. PubMed ID: 23843747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical chemistry for drug discovery and development.
    Roda A
    Anal Bioanal Chem; 2010 Sep; 398(1):27-8. PubMed ID: 20652554
    [No Abstract]   [Full Text] [Related]  

  • 18. Poor quality vital anti-malarials in Africa - an urgent neglected public health priority.
    Newton PN; Green MD; Mildenhall DC; Plançon A; Nettey H; Nyadong L; Hostetler DM; Swamidoss I; Harris GA; Powell K; Timmermans AE; Amin AA; Opuni SK; Barbereau S; Faurant C; Soong RC; Faure K; Thevanayagam J; Fernandes P; Kaur H; Angus B; Stepniewska K; Guerin PJ; Fernández FM
    Malar J; 2011 Dec; 10():352. PubMed ID: 22152094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Technology for combating counterfeit medicine.
    Hall C
    Pathog Glob Health; 2012 May; 106(2):73-6. PubMed ID: 22943539
    [No Abstract]   [Full Text] [Related]  

  • 20. The need for coordinated action against falsified and substandard medicines.
    Seear M
    Int J Tuberc Lung Dis; 2013 Mar; 17(3):286. PubMed ID: 23407216
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.